Grand Bahama is an ideal locale for stem
cell treatments due to the Bahamian government's strong focus on safety and its commitment to the acceleration of regenerative medicine for patients.
Stem
Cell Treatments Due to the ability of adult stem cells to be harvested from the patient, their therapeutic potential is the focus of much research.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates
due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in
treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize
cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program
due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
But while chemotherapy and radiation are associated with temporary changes, such as hair loss and tissue swelling, the
treatments can have an unseen, permanent effect: infertility
due to irreparably damaged sperm or egg
cells.
Unfortunately, the drug usually stops working within a few months,
due to cancer
cells developing resistance to the
treatment.
He has been making that point since 2004, when in testimony to the U.S. Senate, he warned embryonic stem
cell opponent Sam Brownback of Kansas, «Those in a position of advice or authority who participate in the banning or enforced delays of biomedical research that could lead to the saving of lives and the amelioration of suffering are directly and morally responsible for the lives made worse or lost
due to the ban, or even of a moratorium that would deny such
treatments in that short window of time when it could help or save them.»
The study was published in the December issue of Experimental Hematology, the official publication of the Society for Hematology and Stem
Cells, and also highlighted in the journal's editorial
due to its significance in the biology and
treatment of blood cancer.
In the humanized mouse model under the conditions studied here, partial loss of cxcr4 in human T
cells due to
treatment with X4 - ZFNs provided selective pressure for either the evolution or emergence of a pre-existing single amino acid mutation in the V3 loop of the infecting X4 HIV - 1 strain that enabled it to use CCR5 as efficiently as CXCR4.
Due to the aggressive nature of AML, this disease usually requires intensive
treatment, which may include chemotherapy, radiation therapy, immunotherapy and stem
cell transplantation.
Luan said that
due to Brandon's apparent success with the
treatments, he and his wife are going to pay Celltex to bank their stem
cells.
Due to its
cell killing effect, radiation therapy is widely used as a primary source of
treatment for numerous types of cancers.
Research on possible
treatments has been limited
due to ethical concerns over where the stem
cells came from.
5/31/2007 Human Stem
Cell Treatment Restores Motor Function in Paralyzed Rats Rats paralyzed
due to loss of blood flow to the spine returned to near normal ambulatory function six weeks after receiving grafts of human spinal stem
cells (hSSCs), researchers from the University of California, San Diego (UCSD) School of Medicine... More...
Diseases affecting the lung, including emphysema, cystic fibrosis, acute respiratory distress syndrome and pulmonary fibrosis, cause considerable morbidity and mortality in the U.S.. However, there are not many
treatment options available for those diseases, in part
due to the limited availability of human lung
cells for research.
The Regenexx ® family of non-surgical stem -
cell & blood platelet procedures are next generation regenerative injection
treatments for those who are suffering from pain, inflammation or reduced range of motion
due to common elbow injuries, arthritis and overuse conditions.
The best
treatments include blood transfusions or bone marrow transplants from a matched donor, but this is limited
due to the eventual immune response which is mounted against the donated
cells.
The Regenexx ® family of non-surgical stem
cell and blood platelet procedures offer next - generation injection
treatments for those who are suffering from knee pain or may be facing knee surgery or knee replacement
due to common injuries, arthritis, overuse and other conditions.
The landscape of mantle
cell lymphoma is clearly evolving,
due to the availability of new
treatment options incorporating novel biologic agents.
The Regenexx ® family of non-surgical stem -
cell & blood platelet procedures are next generation regenerative injection
treatments for those who are suffering from pain or reduced range of motion
due to basal joint / cmc arthritis, hand arthritis, or other injuries & conditions in the hand.
Dapsone, a leprosy drug, can help some with
treatment resistant Lyme
due to persister
cells.
The brand was originally created for cancer patients that suffer with skin deterioration and
cell regeneration difficulties
due to prolonged
treatments.
Due to its advantages of both safety and affordability, it's non-invasiveness, and the fact that it's drug - free, Stem
Cell Therapy by MediVet Biologics is the most logical cell therapy choice for the treatment of the follow
Cell Therapy by MediVet Biologics is the most logical
cell therapy choice for the treatment of the follow
cell therapy choice for the
treatment of the following:
In most cases the goal for dog cancer
treatment is the complete removal of cancerous
cells remains unachievable
due to quick, progressive and diffusible (spreading deep into the tissue) nature of cancerous
cells.
Treatment of feline plasma cell pododermatitis Since it is believed that feline plasma cell pododermatitis is due to an underlying activation of the immune system, treatment is aimed at controlling the immune
Treatment of feline plasma
cell pododermatitis Since it is believed that feline plasma
cell pododermatitis is
due to an underlying activation of the immune system,
treatment is aimed at controlling the immune
treatment is aimed at controlling the immune response.
Due to advances in veterinary medicine, tests can be applied to mast
cell tumor biopsy samples to determine if certain chemotherapeutic agents should be used for
treatment.